10x Genomics, Inc. (TXG) Operating income 2017–2025
10x Genomics, Inc. (TXG) annual operating income history from SEC filings — each fiscal year as reported.
-$61.0MFY2025 · since FY2017: -$18.4M → -$61.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$61.0M | +68.7% |
| FY2024 | -$194.6M | +26.7% |
| FY2023 | -$265.3M | -58.0% |
| FY2022 | -$167.9M | -221.4% |
| FY2021 | -$52.3M | +90.2% |
| FY2020 | -$534.1M | -1647.1% |
| FY2019 | -$30.6M | +72.4% |
| FY2018 | -$110.8M | -502.8% |
| FY2017 | -$18.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice